Journal of International Oncology 2011;38(2):148-151

doi:10.3760/cma.j.issn.1673-422X.2011.02.022

Targeted therapies for pancreatic cancer

Feiying GU ; Ying YUAN

Keywords

Pancreatic neoplasms; Protein-tyrosine kinases; Monoclonal antibodies

Country

China

Language

Chinese

Abstract

The combination of chemotherapy, radiotherapy and targeted therapies are considered to be major treatments for metastatic pancreatic cancer. At present, the target therapy-related medications include mainly antagonist of epidermal growth factor receptor, monoclonal antibody of vascular endothelial growth factor and so on. Erlotinib combined with gemcitabine has been demonstrated to prolong the survival of patients with pancreatic cancer.